The company's multi-year strategy involves the rollout of new products and upgrades to existing ones that further strengthen its position.

US-based company is developing next-generation sequencers, using AI models in the Republic to speed up diagnostics and lower ...

Nanopore sequencing offers comparable accuracy to short-read NGS for IGH clonotyping in CLL, with advantages in cost and laboratory footprint. The study confirms reliable somatic hypermutation status ...

1 Changsha Hospital of Traditional Chinese Medicine (Changsha Eighth Hospital), Changsha, China 2 Institute of Rehabilitation and Health Care, Department of Rehabilitation and Traditional Chinese ...

SAN DIEGO, Oct. 1, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced the launch of BioInsight, a new business within Illumina, developed to meet industry demand for deeper biologic ...

Illumina Inc. and spun-off Grail Inc. defeated allegations the biotechnology company misled shareholders during the re-acquisition of the latter cancer-detection company. Investors leading the case ...

1 College of Plant Protection, Yunnan Agricultural University, Kunming, China 2 College of Agronomy and Biotechnology, Yunnan Agricultural University, Kunming, China Introduction: The rhizosphere ...

"Illumina has inflicted substantial harm on Element, resulting in lost sales, diminished market share, and reduced profits," counsel for DNA-sequencing company Element Biosciences Inc. alleged in an ...